Abstract
A serious complication of myasthenia gravis is respiratory failure. This may be secondary to an exacerbation of myasthenia (myasthenia crisis) or to treatment with excess doses of a cholinesterase inhibitor (cholinergic crisis). Managing respiratory failure and differentiating a myasthenia from a cholinergic crisis is reviewed. Due to the unpredictable development of respiratory failure, hospitalization is recommended for most patients with exacerbations or complications of myasthenia gravis.
MeSH terms
-
Acetylcholine / immunology
-
Autoantibodies
-
Autonomic Nervous System Diseases / chemically induced
-
Autonomic Nervous System Diseases / diagnosis*
-
Child
-
Cholinesterase Inhibitors / adverse effects*
-
Cholinesterase Inhibitors / therapeutic use
-
Diagnosis, Differential
-
Emergency Medicine
-
Humans
-
Myasthenia Gravis / complications*
-
Myasthenia Gravis / diagnosis
-
Myasthenia Gravis / drug therapy
-
Respiratory Insufficiency / etiology*
Substances
-
Autoantibodies
-
Cholinesterase Inhibitors
-
Acetylcholine